SerenOx Africa is East Africa’s first molecular diagnostics and research centre — delivering genomic testing, haematology expertise, and translational research. Co-founded with Seren, an Oxford University spin-out.
SerenOx Africa integrates molecular diagnostics, clinical expertise, and research to close critical gaps in cancer and haematology care: enabling faster, more accurate, and more equitable diagnosis across the region.
Integrated Diagnostics, Research, and Clinical Care
SerenOx Africa combines advanced molecular diagnostics, translational research, and specialised clinical services to deliver precision medicine solutions across Africa.
Advanced genomic testing including liquid biopsy, next-generation sequencing, and biomarker analysis for cancer and haematological disorders.
Translational research, in-house bioinformatics pipelines, and African genomic data generation – with publications in Nature Medicine, Blood, and Lancet Regional Health: Africa
Specialist haematology and oncology care informed by advanced diagnostics to support personalised, patient-centred treatment.
SerenOx Africa is building a new model for precision medicine by integrating advanced diagnostics, research, and clinical care within the African healthcare ecosystem.
State-of-the-art genomic technologies including next-generation sequencing and liquid biopsy, enabling accurate and early disease detection.
Locally driven research addressing region-specific disease patterns, with global collaboration to generate impactful scientific insights.
Seamless integration of molecular diagnostics with specialist haematology expertise — ensuring every result translates directly into an informed clinical decision.
SerenOx Africa is building practical capacity for precision diagnostics in East Africa — expanding access to advanced testing, supporting timely clinical decisions, and contributing to research that reflects African patient populations.
Flow cytometry analyses performed
Molecular assays completed in-country
Results in hours, not weeks
Hospital and research partnerships across East Africa
Over 300 flow cytometry immunophenotyping analyses and 150+ molecular assays — all performed in-country and reviewed by specialist haematologists.
Our integrated laboratory and clinical model supports the diagnosis and monitoring of acute and chronic leukaemias, helping clinicians make earlier and more informed treatment decisions.
Through targeted molecular testing, liquid biopsy, and region-relevant research, SerenOx Africa is advancing precision, data-driven cancer and haematology care in Africa.
To date, SerenOx Africa has performed over 300+ flow cytometry analyses and more than 150+ molecular assays, with a growing portfolio of advanced genomic and next-generation sequencing tests.
SerenOx Africa contributes to global scientific knowledge through high-impact research, conference presentations, and peer-reviewed publications.
Featured at ASH and EHA, with publications in Nature Medicine, Blood, and Lancet Regional Health – Africa.
Our research integrates clinical insight, molecular diagnostics, and region-specific data to address real-world challenges in cancer and haematology across Africa.
Trusted by leading hospitals, universities, and global life-science partners advancing diagnostics across Africa.
Building a connected ecosystem for precision diagnostics and research in Africa
Whether you’re a clinician, researcher, or organisation, we welcome collaborations, sample referrals, and precision medicine partnerships across Africa.
Fast response • Trusted partners • Research-ready collaborations
